Diabetic ketoacidosis and high mortality among patients with coronavirus disease 2019 in a Peruvian hospital

• Type of Material: Article
• Authors: Eddy Lopez-Huamanrayme, Hospital Nacional Alberto Sabogal Sologuren; Claudia Cordova-Huancas, Hospital Nacional Alberto Sabogal Sologuren; Dioni Garate-Chirinos, Hospital Nacional Alberto Sabogal Sologuren; Frank Espinoza-Morales, Centro de Tecnologías Aplicadas a la Diabetes; Francisco Pasquel, Emory University
• Language: English
• Date: 2021-11-23
• Publisher: WILEY
• Publication Version: Final Published Version
• Copyright Statement: © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1111/jdi.13704
• Title of Journal or Parent Work: JOURNAL OF DIABETES INVESTIGATION
• Volume: 13
• Issue: 4
• Start Page: 746
• End Page: 748
• Keywords: Endocrinology & Metabolism; Science & Technology; Life Sciences & Biomedicine
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

Patients with diabetes and coronavirus disease 2019 (COVID‐19) are vulnerable to the worst outcomes in hospital. Among patients with diabetic ketoacidosis (DKA) treated with standard of care continuous insulin infusion, the mortality reported was up to 30% 1 , significantly higher compared with pre‐pandemic data.